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A mammary nodular lesion was recognized one month before the surgery in the right upper breast of a 55-year-old
female. The fine needle aspiration cytology specimens contained many individual bizarre, multi-nucleated,
and/or giant cells having hyperchromatic pleomorphic nuclei, prominent nucleoli, and relatively abundant
cytoplasm, admixed with numerous mitotic figures in a hemorrhagic or inflammatory background. A small amount
of sheet-like or three-dimensional clusters of malignant cells coexisted. We first interpreted it as high-grade
malignancy, such as invasive carcinoma, not otherwise specified. A right breast-conserving surgery was performed,
and gross examination revealed a cystic cavity-formed and solid tumor lesion, measuring 35 × 35 × 25 mm and
looking gray-yellowish to -whitish. On microscopic examination, the tumor was composed of a diffuse proliferation
of highly atypical cells devoid of adhesive characteristics, including many multi-nucleated giant bizarre cells, in a
haphazard fashion with stromal invasion, alternating with sarcomatoid features of spindle tumor cells. The cystic
cavity was surrounded by hemorrhagic and inflammatory granulation tissue and lined by mostly denuded but
atypical tumor cells or bland-looking flattened epithelial cells. Immunohistochemically, these tumor cells are
specifically positive for all epithelial markers. Therefore, we made a conclusive diagnosis of pleomorphic carcinoma
of the breast with cyst formation. We should be aware that, owing to its characteristic findings, cytopathologists
can diagnose correctly, based on careful cytological examination of adequate samplings.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/9290689448998782
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An entity of mammary pleomorphic carcinoma (PC)
was first established based on the following criteria, as
previously described by Silver and Tavassoli in 2000
[1]: ≥50% of the tumor manifested a pleomorphic cell
population, and tumors of lobular origin were excluded
out. The World Health Organization (WHO) classification* Correspondence: sousuke@med.uoeh-u.ac.jp
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reproduction in any medium, provided the orof tumours of the breast adopts this terminology and
now records PC as a very rare variant of high-grade
invasive carcinoma of no special type, characterized by
proliferation of pleomorphic and bizarre giant cells
comprising >50% of the tumor cells in a background of
adenocarcinoma or adenocarcinoma with spindle and
squamous differentiation [2]. PC is an extremely uncommon
subtype of invasive breast carcinoma, and actually, one
original paper described that less than 0.1% breast tumors
were classified as PCs among a large series of surgically-
resected cases [3]. Silver and Tavassoli have reported that
the average PC tumor size was 5.4 cm, 52% and 12% ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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metastases, respectively, and 38% of them were dead of its
disease (mean disease-specific postoperative survival:
22 months) [1]. Corresponding to most invasive ductal
carcinomas of the breast, PC could be seen at any age, but
tend to occur in the perimenopausal period [1,3], as in the
present case. The authors have confirmed that PC is a
unique entity with a significantly poor outcome [1],
similar to PCs in the other organs, such as lung or small
intestine [4,5]. However, PC of the breast potentially poses
a diagnostic challenge to clinicians and cytopathologists,
since its entity seems to be difficult to conclude a correct
diagnose preoperatively. In fact, we recently have
seen no series of large detailed studies regarding
with cytological findings in PCs of the breast, except for
few case reports previously published [6-8]. Hence, it is
critical to establish an accurate preoperative diagnosis by
fine needle aspiration cytology.
Here, we report a unique surgical case of PC of the
breast, associated with cyst formation. Based on the
cytology specimens, we preoperatively interpreted it
merely as invasive carcinoma, not otherwise specified.
Materials and methods
The patient was a 55-year-old Japanese woman. Fine
needle aspiration cytology from the mammary nodule
was performed, followed by a right breast-conserving
surgery. The tumor specimens after fixation in 10%
neutral buffered formalin were embedded in paraffin
for histological or immunohistochemical examinations.
All immunohistochemical stainings were carried out using
Dako Envision kit (Dako Cytomation Co., Glostrup,
Denmark) according to the manufacturer’s instructions,
and using commercially available prediluted monoclonal
antibodies against the following antigens: cytokeratins
(Cam5.2; Becton Dickinson, San Jose, CA, USA, diluted
1:1, AE1/AE3; Chemicon International, Tamecula, CA,
USA, diluted 1:200, CK5/6; Boehringer Ingelheim Pharma
GmbH & Co. KG, Ingelheim, Germany, diluted 1:50,
34βE12; Leica Microsystems, Wetzlar, Germany, diluted
1:200), EMA (Dako, diluted 1:100), E-cadherin (Becton
Dickinson, diluted 1:1,000), β-catenin (Becton Dickinson,
diluted 1:100), estrogen receptor (ER; BioMed Immunotech,
Inc., Tampa, FL, USA, diluted 1:25), progesterone receptor
(PgR; Dako, diluted 1:6), HER2 protein (Dako, diluted 1:2),
epidermal growth factor receptor (EGFR; Dako, diluted
1:1), p63 (Dako, diluted 1:30), S-100 protein (Dako,
diluted 1:900), CD10 (NOVOCASTRA laboratories Ltd.,
Newcastle, United Kingdom, diluted 1:20), α-smooth
muscle actin (α-SMA; Dako, diluted 1:150), calponin
(Dako, diluted 1:50), vimentin (Dako, diluted 1:100), CD31
(Dako, diluted 1:20), CD34 (BioMed Immunotech, Inc.,
diluted 1:1), D2-40 (Dako, diluted 1:50), desmin (Dako,
diluted 1:150), myogenin (Dako, diluted 1:30), c-kit (SantaCruz Biotechnology, Inc., Santa Cruz, CA, USA, diluted
1:40), CD3 (Dako, diluted 1:1), CD4 (Dako, diluted 1:1),
CD8 (Nichirei Biosciences Inc., Tokyo, Japan, diluted
1:1), CD20 (Dako, diluted 1:200), CD30 (Dako, diluted
1:40), CD45 (Dako, diluted 1:400), CD68 (KP-1; Dako,
diluted 1:100), CD79a (Dako, diluted 1:50), bcl-2 (Dako,
diluted 1:30), p53 (Dako, diluted 1:30), and Ki-67 (MIB-1;
Dako, diluted 1:50). Since all tumor specimens were fixed
in formalin, transmission electron microscopy could not
be performed.
Case presentation
The patient had no history of malignancy, immunosup-
pressive disorders, use of immunosuppressive medications,
or unusual infections. Family history showed that her
aunt also suffered from breast cancer and her father had
colorectal cancer.
She first noticed a nodule in the right breast one month
before the resection. On initial examination, a reddish
swelling mass more than 3 cm in diameter was palpable
mainly in the right upper medial breast. Laboratory data,
including blood cell count, chemistry and tumor markers,
were within normal limits, except for slightly increased
carbohydrate antigen (CA) 15–3 level (35.1 U/mL). Ultra-
sound sonography showed an intracystic tumor lesion,
measuring approximately 3.5 cm in diameter, consisted of
a mixture of a heterogeneously enhanced solid component
and a cystic component on chest CT scans. CT scans of
the head, neck, chest, and abdomen disclosed no definite
evidence of metastases in the lymph nodes or other
organs. MRI revealed a heterogeneous hyperintense cystic
mass on T2-weighted images, associated focally with a
contrast-enhanced irregular wall portion. About 1 month
after surgery, the patient has been medicated on adjuvant
chemotherapy, consisting of four cycles of epirubicin
(120 mg/body), cyclophosphamide (800 mg/body), and
fluorouracil (800 mg/body), and will be followed up with
irradiation. She had neither recurrence nor metastases of
the breast cancer, respectively, and was alive and well at
10 months after the operation.
Pathological findings
The first fine needle aspiration cytology specimens were
consisted mainly of many individual mono- or multi-
nucleated bizarre giant cells (Figure 1A), coexisted with
a small amount of clusters of cohesive and sheet-like or
three-dimensional malignant cells (Figure 1B), in a
hemorrhagic or inflammatory background (Figure 1A–B).
The malignant tumor cells showed markedly large (up
to approximately 100 μm in diameter), hyperchromatic
pleomorphic, and round to oval or spindle nuclei and had
relatively abundant cytoplasm (Figure 1A–B). Additionally,
the nuclei often had prominent nucleoli and numerous




Figure 1 Cytomorphologic examination of the fine needle
aspiration cytology in PC specimens. (A) The cytology specimens
were consisted predominantly of many individual, scattered
malignant giant bizarre cells having often multi-nucleated
pleomorphic nuclei in a hemorrhagic or inflammatory background
(Papanicolaou stains). Bar = 100 μm. (B) A small number of clusters
of cohesive and sheet-like or three-dimensional malignant tumor
cells coexisted. Those malignant cells showed very large (up to
approximately 100 μm in diameter), pleomorphic, and bizarre or
spindle nuclei and had relatively abundant cytoplasm. Additionally,
the nuclei contained conspicuous nucleoli and numerous mitotic
figures including atypical mitoses (arrows) (Papanicolaou stains).




Figure 2 Gross and microscopic examination of the resected PC
specimen. (A) On gross examination, the cut surface revealed a
peripherally cystic cavity-formed, relatively well-defined, and solid
firm mass, measuring 32 × 27 × 25 mm, which looked from gray-
yellowish to -whitish in color. This cystic cavity measured
approximately 15 × 10 mm, filled with hemorrhagic materials. Bar =
5 mm. (B) A scanning magnification (H&E stains) revealed that the
cancer lesions were partly surrounded by the cystic cavity (lt. side)
but irregularly involved its wall in part (rt. side). There were neither
extensive components of intraductal carcinoma nor lobular
carcinoma areas within our thorough investigation. Bar = 5 mm.
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we first interpreted it as high-grade malignancy, such
as invasive carcinoma, not otherwise specified, and an
ordinary right breast-conserving surgery was performed.
On gross examination, the cut surface revealed a peri-
pherally cystic cavity-formed, relatively well-demarcated,
and solid firm mass, measuring 32 × 27 × 25 mm, which
looked from gray-yellowish to -whitish in color (Figure 2A).
This cystic cavity measured approximately 15 × 10 mm,
filled with hemorrhagic but not necrobiotic materials.
The background of the breast had no remarkable change,
e.g., not mastopathic. A scanning magnification of it
showed that the cancer lesions, more than 60% in
volume, were partly surrounded by the cystic cavity
but irregularly involved its wall in part (Figure 2B).
There were neither extensive components of intraductalcarcinoma nor lobular carcinoma areas within our
thorough investigation.
Microscopic findings demonstrated a diffuse prolifera-
tion of large and highly atypical cells devoid of adhesive
characteristics, having hyperchromatic pleomorphic nuclei
and relatively abundant eosinophilic or clear cytoplasm,
admixed with many multi-nucleated bizarre giant cells
and numerous mitotic figures including atypical mitoses,
arranged predominantly in a haphazard fashion with a
chronic and acute inflammatory infiltrate (Figure 3A). By
contrast, a small amount of sarcomatoid components,
consisted mainly of atypical spindle cells, were coexistent
with it (Figure 3B). Apparent keratinization, intercellular
bridge, or intracytoplasmic mucin was not evident.
Our careful histological examination revealed neither
evidences of squamous nor chondro-osseous metaplasia.
On high-power view, emperipolesis of inflammatory cells







Figure 3 Microscopic examination of the PC of the breast. (A) Low power view showed a diffuse proliferation of large and highly atypical
cells devoid of adhesive characteristics, including many multi-nucleated bizarre giant cells (inset), arranged predominantly in a haphazard fashion
with a chronic and acute inflammatory infiltrate (H&E stains). Bar = 400 μm. (B) While, a small amount of sarcomatoid components, consisted
mainly of atypical spindle cells (inset), coexisted. Our careful histological examination revealed neither evidences of squamous nor chondro-
osseous metaplasia (H&E stains). Bar = 1,000 μm. (C) On high-power view, emperipolesis of inflammatory cells was sometimes recognized (H&E
stains). Bar = 100 μm. (D) The cystic cavity was surrounded by hemorrhagic and inflammatory granulation tissue and lined by mostly denuded
but single atypical giant bizarre tumor cells or bland-looking flattened epithelial cells (inset) (H&E stains). Bar = 200 μm.
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matory granulation tissue and lined by mostly denuded
but atypical giant tumor cells or bland-looking flattened
epithelial cells (Figure 3D). The tumor cells partly involved
the adjacent cyst wall but without evidence of apparent
vessel permeation. Neither involvements of fat nor skin
were recognized.
Immunohistochemically, these highly atypical giant
cells were specifically positive for all epithelial markers,
i.e., Cam5.2 (Figure 4A), AE1/AE3, CK5/6, 34βE12
(Figure 4B), and EMA, and focally positive for CD10
(Figure 4C), CD4, and EGFR, whereas negative for E-
cadherin, β-catenin, p63, S-100 protein, α-SMA, calponin,
CD31, CD34, D2-40, desmin, myogenin, c-kit, CD3, CD8,
CD20, CD30, CD45, CD68, CD79a, bcl-2, and p53.
Additionally, sarcomatoid spindle cells were focally
positive for vimentin (Figure 4D). On the other hand,
these tumor cells were completely negative for hormone
receptors (ER and PgR) and HER2, manifesting as
triple-negative breast cancer. MIB-1 labeling index was
approximately 30% in the proliferating malignant cells.
The above tumor-surrounding inflammatory cells were
CD3-positive and CD4-predominant T-lymphocytes,
admixed with CD68-positive histiocytes. All immuno-
histochemical profile of the tumor cells is summarized
in Table 1.
Based on all these features, we indicated that these tumor
cells were characteristic of epithelial differentiation, and
finally made a diagnosis of PC of the breast associated withcyst formation. Final pathological stage was determined as
pT2N0M0, stage IIA, according to the tumour node
metastasis (TNM) system of the Union for International
Cancer Control (UICC) 7th Edition [9].
Discussion
The prognosis of the current PC patient might unusually
appear better than that reported by Silver and Tavassoli
[1], since it is likely that the final diagnosis was made at a
relatively earlier stage of the tumors; even though follow-up
period was not too long in this limited case report.
Actually, our case has shown neither local recurrence
nor metastases for 10 months after the operation. In
contrast, Nguyen et al. recently have described that,
although not all of these PCs behave badly, the presence
of spindle cell sarcomatoid (metaplastic) components or
the tumor size larger than 5 cm significantly leads to
confer a significantly poor prognosis even in the early
stage for PC of the breast [10]. In addition, as shown in
this PC case, no immunohistochemical expression of E-
cadherin and β-catenin, involved in cell adhesion and
cell-cell interaction, very likely results in severe vessel
permeation, advanced clinical stage, and worse outcome
[11,12]. Hence, it would be critical for very early treatment
against PC to establish an accurate preoperative diagnosis
by fine needle aspiration cytology, the clinical utility of
which in diagnosing breast tumors has been already
generalized. The cytological characteristic features of






Figure 4 Immunohistochemical examination of the PC of the breast. (A, B, C, D) The giant bizarre tumor cells of PC were specifically
positive for Cam5.2 (A) and 34βE12 (B), and focally positive for CD10 (C). Additionally, one part of sarcomatoid spindle tumor cells were positive
for vimentin (D). Bars = 50 μm.
Yamada et al. Diagnostic Pathology 2013, 8:75 Page 5 of 7
http://www.diagnosticpathology.org/content/8/1/75ones, exhibiting numerous individual bizarre and giant
malignant cells with pleomorphic irregular nuclei, coarse
chromatin, conspicuous nucleoli, very high mitotic rate,
and relatively abundant cytoplasm in the background of
possible inflammation and/or necrosis [6-8]. Indeed, when
extensive necrosis is present without evidence of viable
PC cells on cytology specimens, cytopathologists should
exclude out the possibility of benign breast tumors, e.g.,
infarcted fibroadenoma [13]. On the other hand, we for
the first time indicate that cohesive, three-dimensional
and/or sheet-like clusters of highly malignant cells coexist
on PC cytology. In fact, the cytological findings of
this relatively new and extremely rare entity have
never been well described or reviewed more recently.
The cytodiagnostics might not need to come out withTable 1 Immunohistochemical profile of the carcinoma








CD10 S-100 protein CD8
CD4 p63 CD20
EGFR calponin CD79a
MIB-1 labeling index 30% myogenin c-KIT
desmin p53such a distinctive one, but should confirm malignancy in
any case of PC of the breast. Despite that, a confident and
accurate diagnosis of PC might be possible only on
cytology specimens, owing to its cytomorphologically
peculiar characteristics, adequate samplings, and/or
accumulated experience. Furthermore, few previous
papers proposed that, when the cytologic features of
invasive ductal carcinoma with bizarre pleomorphic
malignant giant cells were difficult to make an accurate
and conclusive diagnosis, immunostaining for cytokeratins
and EMA on cell blocks of aspirates would be very useful
for the diagnosis of mammary PC [6,8]. Nevertheless, in
cases with evidence of single bizarre giant cells and
clusters of them, as shown here, cytopathologists should
raise high possibility of PC as one of differential diagnoses,
at the very least. Future studies are further needed.
It is possible that the present case report might be
pathologically remarkable for three reasons at least: first,
cystic cavity formation was uniquely recognized within
the tissue of PC. Amongst the ‘true’ cases reported or
retrospectively considered as PC of the breast in the
English literatures [1,3,6-8,10,14], several PC tumors
have displayed nodular or mass lesions with cystic
change or cystic cavity formation [6,8,14], similar to the
present case. We can hypothesize that the cystic cavity
of mammary carcinoma would be formed via multiple
processes: carcinoma cells initially develop in ductal wall
and locally (i.e., intraductally) grow up in volume, and
next block the ductal lumen possibly via their stromal
involvements; and finally, the cystic cavity might gradually
get larger with increased inner pressure and/or possible
necrotic change. However, this hypothesis seems to be
too speculative and not to be based on the
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since it remains to be elucidated whether PCs of the
breast are prone to having cyst formation, it would be
intriguing to study this topic.
Second, we have found the presence of ‘emperipolesis’
wherein surrounding inflammatory cells are engulfed by
tumor giant cells of PC, very similar to pleomorphic
giant cell carcinomas of the lung [15]. According to the
recent, relatively large study of PCs of the breast by
Nguyen et al. [10], many cases of them showed neoplastic
‘cannibalism’ of their tumor cells, but not of inflammatory
cells. However, future thorough studies also will be
further required to determine whether these features
are genuinely characteristic in mammary PCs after
histologically examining a larger number of PC cases.
Third, immunohistochemical analyses of not merely
epithelial markers, including CK5/6 and 34βE12, but
CD10 and vimentin were positively expressed in the
tumor nests. Additionally, ER/PgR/HER2 were all triple-
negative, possibly corresponding to basal-like type breast
cancer [16]. Although there have been no large, detailed
immunohistochemical studies of PC of the breast, to
date, our data imply that those carcinoma cells might have
potential squamous, myoepithelial, and/or basal-like
phenotypes, and epithelial-mesenchymal transition (EMT),
as well, supported by some published papers [14,16].
We might provide the possible evidence that PCs arise
from ductal epithelial-myoepithelial cells, as a result of
neoplastic transformation of outer supporting myoepithelial
cells, as well as inner ductal epithelial cells [17,18].
However, since other myoepithelial markers examined,
such as α-SMA, S-100 protein, p63, and calponin, were
completely negative, this implication would be highly
speculative and unlikely. First of all, pathological differ-
ential diagnosis of this mammary PC case could be
metaplastic carcinoma, and indeed, metaplastic carcin-
oma of the breast include squamous cell carcinomas,
spindle cell carcinomas, or carcinomas with mesenchymal
differentiation [2]. In this context, not only by definition
but from the above immunohistochemistry, it is very
likely that PCs with metaplastic spindle and/or squa-
mous differentiation are metaplastic carcinomas per
se. Some confusion still exists in the newest WHO
classification [2], and thus it could be very challenging that
we pathologists strictly make a final diagnosis as PC of the
breast.
It is possible that, based on these characteristic clinical
and/or cytopathological features, as described above, PC
of the breast might be a special new entity of the breast
cancer, but not a rare variant of invasive carcinoma of
no special type. In this context, the present case report
could interest the scientific community, taken together with
new cytological findings and specific recommendations
for cytodiagnostics.Conclusion
We herein reported an extremely rare case of PC of the
breast associated with cyst formation. The present case
was tentatively made a diagnosis as high-grade invasive
carcinoma, not otherwise specified, on the cytology
specimens, even though its features seemed to be very
characteristic. All cytopathologists should be aware that
its cytomorphologically unique findings from extensively
careful examination can induce one of differential diagno-
ses, and possibly a correct diagnosis.
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